A recent network meta-analysis by Alberts et al. in recurrent prostate cancer concluded that there are only small differences between the three most commonly used PSMA tracers in clinical practice, 68Ga-PSMA-11, 18F-DCFPyl, and 18F-PSMA-1007 [6]. This evidence concerns the gene FOLH1 and prostate carcinoma.